Abstract

Lipid mediators are known to play important roles in the onset and resolution phases of the inflammatory response in mammals. The phospholipid platelet-activating factor (PAF) is a pro-inflammatory lipid mediator which participates in vascular- and innate immunity-associated processes by increasing vascular permeability, by facilitating leukocyte adhesion to the endothelium, and by contributing to phagocyte activation. PAF exerts its function upon binding to its specific receptor, PAF receptor (PAFR), which is abundantly expressed in leukocytes and endothelial cells (ECs). In chickens, lipid mediators and their functions are still poorly characterized, and the role of PAF as an inflammatory mediator has not yet been investigated. In the present study we demonstrate that primary chicken macrophages express PAFR and lysophosphatidylcholine acyltransferase 2 (LPCAT2), the latter being essential to PAF biosynthesis during inflammation. Also, exogenous PAF treatment induces intracellular calcium increase, reactive oxygen species release, and increased phagocytosis by primary chicken macrophages in a PAFR-dependent manner. We also show that PAF contributes to the Escherichia coli lipopolysaccharide (LPS)-induced pro-inflammatory response and boosts the macrophage response to E. coli LPS via phosphatidylinositol 3-kinase/Akt- and calmodulin kinase II-mediated intracellular signaling pathways. Exogenous PAF treatment also increases avian pathogenic E. coli intracellular killing by chicken macrophages, and PAFR and LPCAT2 are upregulated in chicken lungs and liver during experimental pulmonary colibacillosis. Finally, exogenous PAF treatment increases cell permeability and upregulates the expression of genes coding for proteins involved in leukocyte adhesion to the endothelium in primary chicken endothelial cells (chAEC). In addition to these vascular phenomena, PAF boosts the chAEC inflammatory response to bacteria-associated molecular patterns in a PAFR-dependent manner. In conclusion, we identified PAF as an inflammation amplifier in chicken macrophages and ECs, which suggests that PAF could play important roles in the endothelium-innate immunity interface in birds during major bacterial infectious diseases such as colibacillosis.

Highlights

  • Inflammation is a complex and a tightly coordinated biological process driven by a wide array of cells and chemical mediators [1]

  • We provide novel insights into the function of platelet-activating factor (PAF) as a proinflammatory mediator in chickens and the mechanism through which PAF contributes to chicken macrophage activation and responses to bacterial LPS

  • PAF contributes to intracellular bacterial killing and endothelial cells (ECs) dysfunction, two phenomena that may be correlated with the overexpression of PAF receptor (PAFR) and lysophosphatidylcholine acyltransferase 2 (LPCAT2) in organs of chickens presenting colibacillosis

Read more

Summary

Introduction

Inflammation is a complex and a tightly coordinated biological process driven by a wide array of cells and chemical mediators [1]. Lipid mediators (e.g., eicosanoids and phospholipids) are molecules well known to take part in the onset of the inflammatory response in different vertebrate organisms [2, 3] These molecules are rapidly biosynthesized by myeloid and epithelial cells within seconds to minutes of acute stimulation of different origins [1, 4]. Among these molecules, the phospholipid plateletactivating factor (PAF) potent pro-inflammatory lipid mediator. PAF levels in the extracellular milieu can be controlled through rapid degradation by PAF-acetylhydrolase (PAF-AH) [15] All these physiological or pathological processes have been well characterized in mammals, more notably in rodents and humans

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call